Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2016 Dec;87(6):546-553.
doi: 10.1080/17453674.2016.1222804. Epub 2016 Aug 23.

Implant survival of the most common cemented total hip devices from the Nordic Arthroplasty Register Association database

Affiliations
Multicenter Study

Implant survival of the most common cemented total hip devices from the Nordic Arthroplasty Register Association database

Mika Junnila et al. Acta Orthop. 2016 Dec.

Abstract

Background and purpose - According to previous Nordic Arthroplasty Register Association (NARA) data, the 10-year implant survival of cemented total hip arthroplasties (THAs) is 94% in patients aged 65-74 and 96% in patients aged 75 or more. Here we report a brand-level comparison of cemented THA based on the NARA database, which has not been done previously. Patients and methods - We determined the rate of implant survival of the 9 most common cemented THAs in the NARA database. We used Kaplan-Meier analysis with 95% CI to study implant survival at 10 and 15 years, and Cox multiple regression to assess survival and hazard ratios (HRs), with revision for any reason as endpoint and with adjustment for age, sex, diagnosis, and femoral head material. Results - Spectron EF THA (89.9% (CI: 89.3-90.5)) and Elite THA (89.8% (CI: 89.0-90.6)) had the lowest 10-year survivorship. Lubinus (95.7% survival, CI: 95.5-95.9), MS 30 (96.6%, CI: 95.8-97.4), and C-stem THA (95.8%, CI: 94.8-96.8) had a 10-year survivorship of at least 95%. Lubinus (revision risk (RR) = 0.77, CI: 0.73-0.81), Müller (RR =0.83, CI: 0.70-0.99), MS-30 (RR =0.73, CI: 0.63-0.86), C-stem (RR =0.70, CI: 0.55-0.90), and Exeter Duration THA (RR =0.84, CI: 0.77-0.90) had a lower risk of revision than Charnley THA, the reference implant. Interpretation - The Spectron EF THA and the Elite THA had a lower implant survival than the Charnley, Exeter, and Lubinus THAs. Implant survival of the Müller, MS 30, CPT, and C-stem THAs was above the acceptable limit for 10-year survival.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
•••
Figure 2.
Figure 2.
•••
Figure 3.
Figure 3.
•••

References

    1. AOANJRR Australian Orthopaedic Association National Joint Replacement Registry. Annual Report 2015. https://aoanjrr.sahmri.com/
    1. Annaratone G, Surace F M, Salerno P, Regis G F.. Survival analysis of the cemented SP II stem. J Orthopaed Traumatol 2000; 1: 41–5.
    1. Arthursson A J, Furnes O, Espehaug B, Havelin L I, Söreide J A.. Validation of data in the Norwegian Arthroplasty Register and the Norwegian Patient Register: 5,134 primary total hip arthroplasties and revisions operated at a single hospital between 1987 and 2003. Acta Orthop 2005; 76: 823–8. - PubMed
    1. Berli B J, Schäfer D, Morscher E W.. Ten-year survival of the MS-30 matt-surfaced cemented stem. J Bone Joint Surg Br 2005; 87(7): 928–33. - PubMed
    1. Brigstocke G H, Mitchell P A, Rosson J W.. Total hip arthroplasty with the MS-30 polished surface cemented stem: a single surgeon consecutive series study at 10 year follow-up. Eur J Orthop Surg Traumatol 2014; 24(1): 63–6. - PubMed

Publication types

LinkOut - more resources